SEC Form 3 · accession 0001144204-16-126309
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel L. Alkon
Officer — President
Period of report
Sep 23, 2016
Accepted (ET)
Sep 30, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 950,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.75 | holding | — | — | — | — | Aug 23, 2023 | Common Stock | 175,000 | — | D |
Explanation of responses
- F1The stock options shall vest in equal daily installments over a five-year period beginning on the date of grant.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney